MYX 1.02% $4.36 mayne pharma group limited

Ann: MYX signs license agreement for women's health products, page-102

  1. 1,371 Posts.
    lightbulb Created with Sketch. 263
    They employed 75 representatives for Nextellis.
    Trained them for 3-4 months prior to FDA
    approval to sell. The expected Sales and
    Marketing cost projection was $75m.
    Now this financial year outlook sales revenue
    for Nextellis approximately $20m. Even our
    CEO ( new) said should the entire sales staff
    average the same as the top three T/O would
    be 2 and 1/2 times higher. Either the product is
    not being readily taken up or sales staff are just
    order takers. The Royalty Revenue stream deal
    done by TherapeuticsMD with Mayne under the
    situation they were in is extraordinary. An incredably
    good deal on their behalf.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.36
Change
-0.045(1.02%)
Mkt cap ! $369.2M
Open High Low Value Volume
$4.42 $4.45 $4.23 $617.1K 142.1K

Buyers (Bids)

No. Vol. Price($)
7 1069 $4.35
 

Sellers (Offers)

Price($) Vol. No.
$4.36 166 4
View Market Depth
Last trade - 14.36pm 15/07/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.